Capgemini SE ADR (CGEMY)

Capgemini SE ADR is a depositary receipt representing common stock in Capgemini SE and is listed on OTC Markets. The underlying company is an IT services group that provides consulting, digital transformation, technology, and engineering services across regions including North America, France, the United Kingdom, Ireland, the rest of Europe, Asia-Pacific, and Latin America. Its work spans strategy, technology, engineering, data science, creative design, application development, cloud infrastructure, business process outsourcing, transactional services, and IT infrastructure installation and maintenance. Capgemini also develops data and AI-related solutions and has a strategic alliance with OpenAI focused on enterprise AI applications. The company, formerly known as Cap Gemini S.A., adopted the Capgemini SE name in 2017 and is headquartered in Paris, France.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-CGEM.Y
$32.61
60.3% Upside
Bargain
$33.50
64.7% Upside
Bargain
Good
0.59
2.8%
July 30, 2026
9.6x
1.3x
0.7x
17.756 B
25.563 B
37.8%
99.8%
8.2
36.1%
137.1%
Valuation • Fair Value

Capgemini SE ADR (OTC-CGEM.Y) Fair Value by Valuation Model

Compare the primary fair value estimate for Capgemini SE ADR (OTC-CGEM.Y) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$32.61

Estimated upside of 60.3% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$37.88

Discounted cash flow valuation reference.

Ben Graham Formula Value

$23.92

Classic Ben Graham valuation formula reference.

DDM Fair Value

$39.29

Dividend discount model valuation reference.

EPV Fair Value

$22.96

Earnings power value estimate.

Comps Fair Value

$29.59

Comparable-company valuation reference.

Analyst Price Target

$33.50

Analysts imply upside of 64.7%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Capgemini SE ADR (OTC-CGEM.Y) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Capgemini SE ADR (OTC-CGEM.Y)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

26.392 B

Current operating scale indicator.

Revenue Forecast

27.519 B

Forward revenue estimate.

EBITDA

3.403 B

Current operating profitability reference.

EBITDA Forecast

4.42 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Capgemini SE ADR (OTC-CGEM.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Capgemini SE ADR (OTC-CGEM.Y)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.58

No elevated caution signal from this screen.

Altman Z-Score

8.2

Relatively strong balance-sheet zone.

FCF / Net Income

137.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Capgemini SE ADR (OTC-CGEM.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Capgemini SE ADR (OTC-CGEM.Y)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 30, 2026

Days to Earnings

9

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.8%

Income yield reference.

Upcoming Dividend

0.59

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

36.1%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Capgemini SE ADR (OTC-CGEM.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Capgemini SE ADR (OTC-CGEM.Y) Stock Forecast & Technical Outlook

Review Capgemini SE ADR (OTC-CGEM.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Capgemini SE ADR (OTC-CGEM.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Capgemini SE ADR (OTC-CGEM.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Capgemini SE ADR (OTC-CGEM.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Capgemini SE ADR (OTC-CGEM.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Capgemini SE ADR (OTC-CGEM.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Capgemini SE ADR (OTC-CGEM.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Capgemini SE ADR (OTC-CGEM.Y) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

Capgemini SE ADR (OTC-CGEM.Y) Stock FAQ

Quick answers about Capgemini SE ADR (OTC-CGEM.Y) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$32.61
Estimated upside 60.3%
Valuation Rating
Undervalued
Estimated upside of 60.3%
Analyst Target
$33.50
Implied upside 64.7%
Financial Health
Good
Current financial-health read

The current fair value estimate for Capgemini SE ADR (OTC-CGEM.Y) is $32.61. This implies an estimated upside of 60.3% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 60.3% versus the current market price.

The available analyst price target for Capgemini SE ADR (OTC-CGEM.Y) is $33.50. The analyst target implies estimated upside of 64.7%.

The current financial health read for Capgemini SE ADR (OTC-CGEM.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Capgemini SE ADR (OTC-CGEM.Y) is July 30, 2026.

Based on the current data, dividend yield is 2.8%, upcoming dividend amount is 0.59.

The current P/E ratio listed for Capgemini SE ADR (OTC-CGEM.Y) is 9.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Capgemini SE ADR is 17.756 B.

The current enterprise value listed for Capgemini SE ADR is 25.563 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Capgemini SE ADR is OTC-CGEM.Y, and the stock is listed on OTC Markets.

Capgemini SE ADR (OTC-CGEM.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Capgemini SE ADR is 37.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Capgemini SE ADR is 99.8%. Free float helps investors understand how much of the share base is available for public trading.